Who develops written policies and procedures for drug therapy along with the pharmacist?

The Quality Assurance Committee is responsible for developing written policies and procedures for drug therapy in collaboration with the pharmacist. This committee plays a vital role in ensuring that the nursing home adheres to regulatory requirements and standards of practice, including safe medication management. Their work focuses on quality improvement initiatives that enhance resident care and safety, making it essential for them to be involved in drug therapy policy development.

By working together with the pharmacist, the Quality Assurance Committee can ensure that the policies reflect current best practices, address potential areas of risk, and facilitate effective communication among the healthcare team. This collaborative approach helps in managing medication administration, monitoring for adverse effects, and ensuring compliance with both state and federal regulations.

The involvement of this committee is crucial as it not only fosters a culture of safety and accountability but also enables continuous evaluation and improvement of drug therapy practices, ultimately benefitting the health and well-being of residents in the nursing home setting.